Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Extrapulmonary Tuberculosis in Denmark From 2009 to 2014; Characteristics and Predictors for Treatment Outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Luteinizing Hormone Receptor Is Expressed in Testicular Germ Cell Tumors: Possible Implications for Tumor Growth and Prognosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effects of Antibiotics on the Intestinal Microbiota of Mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Transplant recipients are an immunologically vulnerable patient group and are at elevated risk of Clostridioides difficile infection (CDI) compared with other hospitalized populations. However, risk factors for CDI post-transplant are not fully understood.

Methods: Adults undergoing solid organ (SOT) and hematopoietic stem cell transplant (HSCT) from January 2010 to February 2017 at Rigshospitalet, University of Copenhagen, Denmark, were retrospectively included. Using nationwide data capture of all CDI cases, the incidence and risk factors of CDI were assessed.

Results: A total of 1687 patients underwent SOT or HSCT (1114 and 573, respectively), with a median follow-up time (interquartile range) of 1.95 (0.52-4.11) years. CDI was diagnosed in 15% (164) and 20% (114) of the SOT and HSCT recipients, respectively. CDI rates were highest in the 30 days post-transplant for both SOT and HSCT (adjusted incidence rate ratio [aIRR], 6.64; 95% confidence interval [CI], 4.37-10.10; and aIRR, 2.85; 95% CI, 1.83-4.43, respectively, compared with 31-180 days). For SOT recipients, pretransplant CDI and liver and lung transplant were associated with a higher risk of CDI in the first 30 days post-transplant, whereas age and liver transplant were risk factors in the later period. Among HSCT recipients, myeloablative conditioning and a higher Charlson Comorbidity Index were associated with a higher risk of CDI in the early period but not in the late period.

Conclusions: Using nationwide data, we show a high incidence of CDI among transplant recipients. Importantly, we also find that risk factors can vary relative to time post-transplant.

Original languageEnglish
JournalOpen Forum Infectious Diseases
Volume6
Issue number4
Pages (from-to)ofz086
ISSN2328-8957
DOIs
Publication statusPublished - 19 Feb 2019

    Research areas

  • CDI, Clostridioides difficile infection, hematopoietic stem cell transplantation, solid organ transplantation

ID: 56962273